Pfizer Clinches $10 Billion Metsera Deal As Novo Nordisk Loses Weight

Pfizer (PFE) has reached a deal to buy Metsera (MTSR), a weight-loss drug startup, in a transaction that could total more than $10 billion. The agreement follows a back-and-forth negotiation with Novo Nordisk (NVO), which attempted to counter Pfizer’ ...Read more